GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Torrent Pharmaceuticals Ltd (BOM:500420) » Definitions » Retained Earnings

Torrent Pharmaceuticals (BOM:500420) Retained Earnings : ₹0 Mil (As of Sep. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Torrent Pharmaceuticals Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Torrent Pharmaceuticals's retained earnings for the quarter that ended in Sep. 2024 was ₹0 Mil.

Torrent Pharmaceuticals's quarterly retained earnings declined from Mar. 2024 (₹39,424 Mil) to Jun. 2024 (₹0 Mil) but then stayed the same from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹0 Mil).

Torrent Pharmaceuticals's annual retained earnings increased from Mar. 2022 (₹29,167 Mil) to Mar. 2023 (₹33,032 Mil) and increased from Mar. 2023 (₹33,032 Mil) to Mar. 2024 (₹39,424 Mil).


Torrent Pharmaceuticals Retained Earnings Historical Data

The historical data trend for Torrent Pharmaceuticals's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Torrent Pharmaceuticals Retained Earnings Chart

Torrent Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18,930.30 28,064.70 29,166.80 33,031.90 39,424.00

Torrent Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 39,424.00 - -

Torrent Pharmaceuticals Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Torrent Pharmaceuticals  (BOM:500420) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Torrent Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Off Ashram Road, Torrent House, Ahmedabad, GJ, IND, 380009
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.

Torrent Pharmaceuticals Headlines

No Headlines